The Investigation of Selective Sphingosine-1 Phosphate Receptor 1 and 4 Modulator to Treat Alopecia Areata Mouse Model
November 2025
in “
The Journal of Immunology
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → Studysummary This study found that administering an S1PR 1&4 modulator reduced alopecia areata lesion size and decreased CD8+ T cell infiltration in mice, suggesting potential as a treatment for this condition.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study investigates the use of a selective sphingosine-1 phosphate receptor (S1PR) 1&4 modulator as a treatment for alopecia areata (AA) in a mouse model. AA is an autoimmune disease characterized by hair loss, involving NKG2D+ CD8+ T cells. The S1PR modulator, known for its role in immune and inflammatory reactions, was administered orally to AA mice for 12 weeks. Results showed a significant decrease in AA lesion size and an increase in the disease-free ratio compared to the control group. Additionally, there was a reduction in CD8+ T cell infiltration in the skin lesions and decreased NKG2D levels in effector CD8+ T cells. Bulk RNA-sequencing confirmed a reduction in receptor internalization and cytotoxicity at the transcriptome level. These findings suggest that the S1PR 1&4 modulator could be a promising treatment for AA.
